NCT07565818Active, not recruiting
Spectral CT Combined With MSI for Predicting Regional Lymph Node Metastasis in Gastric Cancer
Source: ClinicalTrials.gov · Last updated 4 May 2026
Brief summary (registry, in English)
This study prospectively collected spectral CT imaging data and clinical information related to gastric cancer, evaluated the diagnostic efficacy of its image quality for regional lymph nodes in gastric cancer, and explored its application value in the N staging of gastric cancer with different MSI statuses, so as to provide a more accurate evidence for clinical diagnosis, promote the development of individualized treatment for gastric cancer, and ultimately improve the prognosis of patients.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 260 (estimated)
- First submitted
- 27 Apr 2026
- Start date
- 4 Aug 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Yunnan Cancer Hospital
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT07565818
What you commit to
- Study type: Interventional
- Planned participants: 260
- From 4 Aug 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- (a)Combined with other primary tumors;
- (b) The image quality does not meet the diagnostic criteria;
- (c)Those who cannot tolerate CT examination.
Who the study is looking for
- (a)Patients with gastric adenocarcinoma confirmed by histopathological biopsy and definite microsatellite status determined by immunohistochemistry (IHC);
- (b)Abdominal dual-phase Quark CT scanning was performed within 2 weeks before surgery;
- (c)aged ≥ 18 years old
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yunnan Cancer Hospital Coordinator of this site? Confirm its status | Kunming | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.